Dr. Rachel J Bishop received a master degree on Public Health from Johns Hopkins Bloomberg School of Public Health. Dr. Bishop examines and cares for people who are participating in clinical trials throughout the many Institutes and Centers at the NIH. This involves monitoring medication and treatment side-effects, managing eye diseases, and performing eye surgeries. In addition, she is the co-lead on a 5-year study of the ocular effects of Ebola on survivors in Liberia, part of the PREVAIL Ebola survivor study. Dr. Bishop specializes in the treatment of ocular graft-versus-host disease, a condition affecting patients who have received a donor stem cell transplant in which the transplanted immune cells attack and destroy the tear-producing glands of the eye, resulting in severe dry eye. From 2003-2006, Dr. Bishop provided ophthalmic care to thousands of soldiers before or after their deployments to Afghanistan and Iraq, as the chief of ophthalmology at Darnall Army Community Hospital in Fort Hood, Texas. Prior to receiving her medical degree, she served as executive officer of a medical company for the Virginia Army National Guard, and completed active duty Army assignments as an administrator at Letterman U.S. Army Hospital in San Francisco and company executive officer within the Second Infantry Division in South Korea.

General ophthalmology and Ocular graft-versus-host disease